Home
Perceptive Xontogeny Venture Fund, Director: Astria Therapeutics ATXS Buy · Filed 23/10/18
Trade details
- Type
- Insider buy
- Amount
- $3,997,543.62
- Shares · price
- 614,062 sh · $6.51 a share
- Held after
- 1,652,371 sh
- Trade date
- 23/10/16
- Filed
- 23/10/18
- Days to filing
- 2 days
4 insiders bought this week
- Insiders buying this week
- 4 insiders
- Holding change
- +59.1%
Astria Therapeutics trades, last 26 weeks
What else happened in Astria Therapeutics around then
Filed or reported within 30 days of the trade day · 23/09/16~23/11/15Perceptive Xontogeny Venture Fund's recent trades
- Perceptive Xontogeny Venture Fund
BuySolid Biosciences
BuySolid Biosciences
SLDB
$20.2M
5,000,000 sh
$20.2M
Filed 25/02/21
Traded 25/02/19
- Perceptive Xontogeny Venture Fund
BuyAstria Therapeutics
BuyAstria Therapeutics
ATXS
$30M
2,481,350 sh
$30M
Filed 24/02/05
Traded 24/02/01
- Perceptive Xontogeny Venture Fund
BuySolid Biosciences
BuySolid Biosciences
SLDB
$18.9M
3,410,713 sh
$18.9M
Filed 24/01/12
Traded 24/01/11
- Perceptive Xontogeny Venture Fund
BuyAstria Therapeutics
BuyAstria Therapeutics
ATXS
$4.6M
740,000 sh
$4.6M
Filed 23/12/22
Traded 23/12/21
- Perceptive Xontogeny Venture Fund
BuyAstria Therapeutics
BuyAstria Therapeutics
ATXS
$3M
460,546 sh
$3M
Filed 23/10/18
Traded 23/10/16
